(Q37474363)

English

Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial (English)

1 reference

Europe PubMed Central

20 August 2017

1 reference

based on heuristic

inferred from title

JoAnn E. Manson

9

object named as

Joann E Manson

1 reference

Europe PubMed Central

20 August 2017

1

object named as

Anne McTiernan

1 reference

Europe PubMed Central

20 August 2017

Rowan T Chlebowski

2

object named as

Rowan T Chlebowski

1 reference

Europe PubMed Central

20 August 2017

author name string

Christopher Martin

3

1 reference

Europe PubMed Central

20 August 2017

Jennifer David Peck

4

1 reference

Europe PubMed Central

20 August 2017

Aaron Aragaki

5

1 reference

Europe PubMed Central

20 August 2017

Etta D Pisano

6

1 reference

Europe PubMed Central

20 August 2017

C Y Wang

7

1 reference

Europe PubMed Central

20 August 2017

Karen C Johnson

8

1 reference

Europe PubMed Central

20 August 2017

Robert B Wallace

10

1 reference

Europe PubMed Central

20 August 2017

Mara Z Vitolins

11

1 reference

Europe PubMed Central

20 August 2017

Gerardo Heiss

12

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

9 November 2009

1 reference

Europe PubMed Central

20 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

20 August 2017

27

1 reference

Europe PubMed Central

20 August 2017

36

1 reference

Europe PubMed Central

20 August 2017

6135-6143

1 reference

Europe PubMed Central

20 August 2017

Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Breast cancer risk factors in relation to breast density (United States).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

The Women's Health Initiative recruitment methods and results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Overview of the main outcomes in breast-cancer prevention trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Tamoxifen and mammographic breast densities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

23 August 2017

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

6 September 2017

Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

14 September 2017

Mammographic features and breast cancer risk: effects with time, age, and menopause status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

26 June 2018

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Mammographic density and estrogen receptor status of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Mammographic density and breast cancer in three ethnic groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Postmenopausal hormone therapy and change in mammographic density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Biological significance of interventions that change breast density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

A longitudinal study of the effects of menopause on mammographic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Effects of a short-term suspension of hormone replacement therapy on mammographic density.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Effects of mammographic density and benign breast disease on breast cancer risk (United States).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Effect of tamoxifen on mammographic density.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793034

2 September 2018

The detection of change in mammographic density

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901118

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901118

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901118

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammographic densities and breast cancer risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901118

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19901118

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.21.7166

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37474363&oldid=2145885795"